CONTACT US
Share: Share on Facebook Share on Twitter Share on LinkedIn I recommend visiting cushmanwakefield.com to read:%0A%0A {0} %0A%0A {1}
Life Sciences Golden Triangle Report Life Sciences Golden Triangle Report

Life Sciences: Golden Triangle Lab Report

Jamie Renison • 06/11/2024

Q3 2024 Take-Up Statistics

  • Golden Triangle leasing activity totalled 84,400 sq ft in Q3 2024.
  • Under-offer space totalled 262,700 sq ft at the close of Q3, indicating that activity will likely continue to rebound in Q4.

Evolving Demand and Supply

  • Construction completions for the quarter totalled 124,000 sq ft across the Golden Triangle life sciences market, with five schemes being delivered.
  • At the close of the quarter, 4.3 million sq ft of space was under construction across the Golden Triangle. Of this, 12% has been pre-let, leaving a speculative under-construction pipeline of 3.7 million sq ft.
  • A vacancy rate of 1.3% in Cambridge suggests that some supply-demand imbalances in the Golden Triangle remain, but availability in markets such as Oxford and London continues to rise – although both are smaller markets compared to Cambridge and are therefore more sensitive to new deliveries.
  • Prime headline quoting rents in Q3 2024 remained level in all markets, with Cambridge at £77.00 psf, Oxford at £62.50 and London at £130.00 (based on a notional Cat-A comprising shell and core handover condition plus a tenant improvements allowance).

Venture Capital

  • New Venture Capital (VC) funding into UK life sciences companies totalled £820.4 million in Q3 2024, which is 17% above the five-year quarterly average.
  • London reported the largest share of VC investment at 63%, equating to £514.0 million – the second highest figure on record for the London market.
  • The M&A market accelerated in Q3, with IPOs assisted by the improving interest rate outlook.

Investment Market Insights

  • £289 million transacted during the first three quarters of 2024, with the Golden Triangle life sciences real estate investment market seeing a continuation of the subdued volumes of investment experienced since 2023.
  • However, looking ahead, over £260m of transactions in the Golden Triangle were under offer in Q3, of which a number have subsequently transacted after the quarter close.
  • Prime yields in the Golden Triangle remained flat over the quarter, at 5.00%.
  • Further cuts to interest rates, combined with lower inflation and increased occupier demand could provide the conditions to stimulate greater investment appetite in the coming quarters.

Read more in our latest quarterly report External Link or get in touch with a member of the team to discuss further.

Resources

09.2024-life-sciences-update_web-card.jpg
Research

Life Sciences Update

Cushman & Wakefield’s 2024 life sciences market report covers national trends and dive deep into top global life sciences markets, for an in-depth look at this quickly changing industry. 
Sandy Romero • 17/09/2024
Locating science
Research

Locating Science

Assessing the Life Sciences landscape across the UK
10/05/2024
istockphoto-idea
GSK Completes Sale Of Strategic Life Sciences Development Site

Real estate services firm Cushman & Wakefield has advised GSK plc on the sale of the surplus development land that sits alongside its 1 million sq ft Research & Development (R&D) facility in Stevenage to UBS Asset Management and Reef Group. 

11/11/2022

Ready to talk?

Get in touch with one of our professionals.
With your permission we and our partners would like to use cookies in order to access and record information and process personal data, such as unique identifiers and standard information sent by a device to ensure our website performs as expected, to develop and improve our products, and for advertising and insight purposes.

Alternatively click on More Options and select your preferences before providing or refusing consent. Some processing of your personal data may not require your consent, but you have a right to object to such processing.

You can change your preferences at any time by returning to this site or clicking on Cookies.
MORE OPTIONS
Agree and Close
These cookies ensure that our website performs as expected,for example website traffic load is balanced across our servers to prevent our website from crashing during particularly high usage.
These cookies allow our website to remember choices you make (such as your user name, language or the region you are in) and provide enhanced features. These cookies do not gather any information about you that could be used for advertising or remember where you have been on the internet.
These cookies allow us to work with our marketing partners to understand which ads or links you have clicked on before arriving on our website or to help us make our advertising more relevant to you.
Agree All
Reject All
SAVE SETTINGS